News and Comments

ARCA BIOPHARMA: A GENETICALLY TARGETED DRUG FOR ATRIAL FIBRILLATION IN HEART FAILURE PATIENTS

  Thursday, January 09, 2014

A Colorado-based biopharmaceutical company, ARCA Biopharma (ABIO) has a genetically-targeted drug, GencaroTM (bucindolol hydrochloride), for Atrial fibrillation (AF) in patients with heart failure (HF). The drug offers a personalized medicine approach for the treatment of AF in HF, treating only individuals with certain genetic characteristics. This approach enables the selection of individuals who would most probably respond to the drug through excluding the expected non-responders, thus reducing statistically failed trial outcome, in addition to decreasing clinical trial and healthcare costs.    More...


Recent Postings


Archive


Tags

CRISPR Therapeutics (CRSP) CompuGen (CGEN) Galena (GALE) Trastuzumab-DM1 SYNTA (SNTA) ACADIA (ACAD) AERIE PHARMACEUTICALS LEXICON (LXRX) Genentech Incyte (INCY) Biogen Idec (BIIB) IDERA (IDRA) Gilead (GILD) Advaxis (ADXS) Sanofi (SNA) ADVENTRIX (ANX) Global Cell Therapeutics (GBT) NANTKWEST (NK) Intermune (ITMN) Multiple Myeloma Ionis (IONS) Array Pharmaceuticals (ARRY) Merck (MRK) Intrexon (XON) AGOS (ARGS) HALOZYME (HALO) C4 Therapeutics KERYX (KERX) Bellicum (BLCM) Anadys (ANDS) Xoma (XOMA) NOVOCURE (NVCR) Benlysta (belimumab) Ziofpharm (ZIOP) ISIS (ISIS) Human Longevity (HLI) Alder Biopharmaceuticals (ALDR) Dendreon (DNDN) Agenus (AGEN RenenxBio (RGNX) Roche (RHHBY) Pluristem (PSTI) Exelixis (EXEL) GUARDIAN HEALTH Bristol-Myers Squibb (BMY) Ridaforolimus PORTOLA (PTLA) Telaprevir ImmunoGen (IMGN) BIOMARIN (BMRN) Human Genome Sciences (HGSI) Theravance Bio Pharma (TBPH) Dynavax (DVAX) Seattle Genetics (SGEN) Velcade (bortezomib) Jazz Pharmaceuticals (JAZZ) KITE (KITE) Tysabri Vitae Pharmaceuticals (VTAE) Sarepta (SRPT) TOKAI (TKAOI) Aimmune Therapeutics (AIMT) REGULUS (RGLS) Intercept (ICPT) Rapamune Sequenom (SQNM) Adaptimmune (ADAP) Prolor Biotech (PBTH) Sanofi-Aventis (SAN) ZALTRAP™ MODERNA Regeneron (REGN) Mirati Therapeutics (MRTX) Prosensa (RNA) ARGOS (ARGS) Sangamo (SGMO) Sanofi (SNY) NEKTAR (NKTR)) Revlimid (lenolidamide) Idenix (IDIX) Illumina (ILMN) Anacor (ANAC) AstraZeneca (AZN) Elan (ELN) Valeant Pharmaceuticals International (VRX) ABBVIE (ABBV) OSI (OSIP) Alnylam (ALNY) JOUNCE THERAPEUTICS (JNCE) Spike Therapeutics (ONCE) Amgen (AMGN) Onyx (ONXX) CEMPRA (CEMP) Zerenex galapagos (GLPG) Abbott Laboratories (ABT) Ariad (ARIA) Vertex (VRTX) JUNO (JUNO) Editas (EDIT) SUNESIS PHARMACEUTICALS (SNSS) Herceptin Ocular Therapeutix (OCUL) Endometrial Cancer GlaxoSmithKline (GSK) Cytokinetics (CYTK) VANDA (VNDA) Biocryst (BCRX) Micromet (MITI) ARCA (ABIO) INNOVIVA (INVA) Agenus (AGEN) PTC Therapeutics (PTCT) Roche (ROCHE) SERES THERAPEUTICS (MCRB) Theravance (THRX) OncoCyte (OCX) Auspex (ASPX) Inovio (INO)